MNIVF (Monash IVF Group) Valuation Rank


MNIVF Monash IVF Group Ltd MNIVF
76 GF Score
Price $0.40
GF Value $0.78
! 8 Warning Signs
View Full Analysis

What is Monash IVF Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Monash IVF Group Valuation Rank Related Terms

MNIVF
76GF Score
Monash IVF Group Ltd MNIVF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Monash IVF Group (MNIVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of $0.40 is trading 48.7% below its estimated GF Value™ of $0.78.

Key valuation signals for MNIVF:

  • Valuation Rank:
  • GF Value™: $0.78 vs. price of $0.40 (48.7% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monash IVF Group Business Description

Other Exchanges MVF:Australia
Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
76GF Score

Get the complete analysis for MNIVF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.78
GF Value